🔗 Share this article

A shadow market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid British shipping. Sellers promote the drug there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with numerous of users, filled with photos of slimming results, positive reviews and detailed instructions for mixing or injecting at residence.

After minutes of entering one group, a seller posted contact information, where most purchases take place. The seller provided an instruction manual and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.

Item Information and Pricing

Within these groups, messages display black plastic parcels with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they cannot confirm. Although the science behind this drug is sound, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously seen individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially significant health risks”.